H. Lundbeck A Logo

H. Lundbeck A

Develops and commercializes innovative therapeutics for brain diseases globally.

HLUN | CO

Overview

Corporate Details

ISIN(s):
DK0061804697 (+5 more)
LEI:
5493006R4KC2OI5D3470
Country:
Denmark
Address:
Ottiliavej 9, 2500 Valby
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

H. Lundbeck A/S is a global pharmaceutical company dedicated exclusively to developing and commercializing innovative treatments for brain diseases. The company's core focus is on neuroscience, engaging in the full value chain of research, development, manufacturing, and sales of therapeutics for psychiatric and neurological disorders. Its portfolio addresses a variety of conditions, including depression, migraine, and rare epilepsies. With a mission to advance brain health, Lundbeck markets its specialized products in numerous countries worldwide, managing operations from initial research to patient delivery.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-20 08:00
Regulatory News Service
English 146.2 KB
2025-09-20 08:00
Legal Proceedings Report
English 30.0 KB
2025-08-13 18:41
Interim Report
English 1.0 MB
2025-08-13 18:41
Earnings Release
English 32.1 KB
2025-08-13 18:35
Earnings Release
English 24.2 KB
2025-08-13 18:35
Earnings Release
English 129.5 KB
2025-02-21 13:27
Director's Dealing
English 124.1 KB
2025-02-21 13:27
Director's Dealing
English 29.9 KB
2025-02-05 16:40
Director's Dealing
English 134.1 KB
2025-02-05 16:40
Director's Dealing
English 96.6 KB
2025-02-05 07:46
Annual Report
English 6.4 MB
2025-02-05 07:46
Report Publication Announcement
English 2.9 KB
2025-02-05 07:46
Annual Report (ESEF)
English 13.1 MB
2025-02-05 07:24
Earnings Release
English 33.3 KB
2025-02-05 07:24
Earnings Release
English 443.0 KB

Automate Your Workflow. Get a real-time feed of all H. Lundbeck A filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for H. Lundbeck A via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Synbiotic SE Logo
A vertically integrated European group for the entire hemp and cannabis value chain.
Germany SBX
Synektik S.A. Logo
Manufactures radiopharma; provides medical equipment, IT solutions, and services to specialists.
Poland SNT
Biotech firm developing drugs, medical devices & microbial culture media for hospitals & industry.
South Korea 048870
Synthaverse S.A. Logo
Develops and sells oncology, hematology, and immunology drugs and vaccines globally.
Poland BML
TAIKO PHARMACEUTICAL CO., LTD. Logo
Manufactures OTC gastrointestinal medicine and leading infection control products.
Japan 4574
TAKARA BIO INC. Logo
Provides life science research tools, gene therapies, and CDMO services for improving human health.
Japan 4974
Takeda Pharmaceutical Company Limited Logo
R&D-driven biopharma creating medicines for Oncology, Rare Diseases, GI, and Neuroscience.
Japan 4502
TAUNS Laboratories, Inc. Logo
Develops and sells in vitro diagnostics and research reagents, like antigen tests, globally.
Japan 197A
Tchaikapharma High Quality Medicines AD Logo
Develops and makes affordable generic drugs for cardiovascular & metabolic diseases.
Bulgaria THQM
TDSPHARM Co., Ltd. Logo
Develops and manufactures transdermal drug delivery systems like patches, plasters, and OTC products.
South Korea 464280

Talk to a Data Expert

Have a question? We'll get back to you promptly.